{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:24:23Z","timestamp":1778315063663,"version":"3.51.4"},"reference-count":20,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2020,2,29]]},"DOI":"10.5582\/irdr.2019.01094","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T22:03:59Z","timestamp":1580767439000},"page":"43-47","source":"Crossref","is-referenced-by-count":16,"title":["Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy"],"prefix":"10.5582","volume":"9","author":[{"given":"Anika","family":"Agrawal","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Maulana Azad Medical College, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karamalla Saddam","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Maulana Azad Medical College, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Maulana Azad Medical College, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bhutani VK, Zipursky A, Blencowe H, <i>et al<\/i>. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013; 74 Suppl 1:86-100.","DOI":"10.1038\/pr.2013.208"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Geaghan SM. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization. SeminPerinatol. 2011; 35:148-154.","DOI":"10.1053\/j.semperi.2011.02.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4. Eder AF. Update on HDFN: new information on long-standing controversies. Immunohematology. 2006; 22:188-195.","DOI":"10.21307\/immunohematology-2019-379"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5. Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion. 2008; 48:941\u2013952.","DOI":"10.1111\/j.1537-2995.2007.01625.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6. Geoff D, Imelda B. The Rh blood group system. In: Essential guide to blood groups. Blackwell Publishing, Amsterdam, the Netherlands, 2007; pp 33-44.","DOI":"10.1002\/9780470750926.ch4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7. Roberts IA. The changing face of haemolytic disease of the newborn. Early Hum Dev. 2008; 84:515-523.","DOI":"10.1016\/j.earlhumdev.2008.06.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004; 114:297-316.","DOI":"10.1542\/peds.114.1.297"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B.The Denver II: a major revision and restandardization of the Denver Developmental Screening Test. Pediatrics.1992; 89:91-97.","DOI":"10.1542\/peds.89.1.91"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Kornstad L. New cases of irregular blood group antibodies other than anti Rh D in pregnancy: frequency and clinical significance. ActaObstetGynecol Scand. 1983; 62:431-436.","DOI":"10.3109\/00016348309154215"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11. Thakral B, Agrawal SK, Dhawan HK, Saluja K, Dutta S, Marwaha N. First report from India of haemolytic disease of the newborn by anti c and anti E in Rh (D) positive mothers. Haematology. 2007; 12:377-380.","DOI":"10.1080\/10245330701448438"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Wu KH, Chu SL, Chang JG, Shih MC, Peng CT. Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfus Med. 2003; 13:311-314.","DOI":"10.1046\/j.1365-3148.2003.00458.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13. Basu S, Kaur R, Kaur G. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J Transfus Sci. 2011; 5:3-7.","DOI":"10.4103\/0973-6247.75963"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, Allard S, British Committee for Standards in Haematology. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016; 26:246-263.","DOI":"10.1111\/tme.12299"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15. Azuonwu O, Nnenna I, Douglass SA, Ntaa BN. Consequences of haemolytic disease of the fetus and newborn (HDFN) and the clinical significance of antibody screening in prenatal diagnosis: a study of multigravidal and primigravidal women in Port Harcourt, Niger Delta. Journal of Clinical and Laboratory Medicine. 2016; doi http:\/\/dx.doi.org\/10.16966\/2572-9578.106","DOI":"10.16966\/2572-9578.106"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Slootweg YM, Koelewijn JM, Van Kamp IL, Van der Bom JG, Oepkes D, De Haas M. Third trimester screening for alloimmunisation in Rh(c) negative pregnant women: evaluation of the Dutch national screening programme. BJOG. 2016; 123:955-963.","DOI":"10.1111\/1471-0528.13816"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Smith HM, Shirey RS, Thoman SK, Jackson JB. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility. Immunohematology. 2013; 29:127-130.","DOI":"10.21307\/immunohematology-2019-134"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Pal M, Williams B. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology. 2015; 47:151-155.","DOI":"10.1097\/PAT.0000000000000225"},{"key":"18","unstructured":"19. Guidelines for Blood Grouping &amp; Antibody Screening in the Antenatal and Perinatal Setting. 2<sup>nd<\/sup> Edition 2004, Prepared by Scientific Subcommittee of the Australian and New Zealand Society of Blood Transfusion Inc."},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Moinuddin I, Fletcher C, Millward P. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med. 2019; 10:283-289.","DOI":"10.2147\/JBM.S214118"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. ACOG Practice Bulletin No. 192: Management of alloimmunization during pregnancy. Obstet Gynecol. 2018; 131:e82-e90.","DOI":"10.1097\/AOG.0000000000002528"}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/9\/1\/9_2019.01094\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T05:59:44Z","timestamp":1665727184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/9\/1\/9_2019.01094\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2019.01094","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,29]]}}}